Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

被引：0
|
作者：
Amir, E. [1 ]
Broom, R. [1 ]
Freedman, O. [1 ]
Ooi, W. S. [1 ]
Done, S. [2 ]
Gianfelice, D. [3 ]
Barth, D. [1 ]
Kahn, H. [4 ]
Clemons, M. [1 ]
机构：
[1] Princess Margaret Hosp, Div Hematol & Med Oncol, Toronto, ON M4X 1K9, Canada
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Intervent Radiol, Toronto, ON, Canada
[4] Sunnybrook Med Ctr, Dept Pathol, Toronto, ON, Canada
来源：
BREAST CANCER RESEARCH | 2009年 / 11卷
关键词：
Breast Cancer; Estrogen Receptor; Progesterone Receptor; Bone Metastasis; Receptor Status;
D O I：
10.1186/bcr2310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Effects of rat bone marrow-derived mesenchymal stem cells on breast cancer cells with differing hormone receptor status
    Wang, Ying
    Shao, Shan
    Luo, Minna
    Huang, Shangke
    Feng, Lu
    Yuan, Na
    Wu, Fang
    Dang, Chengxue
    Zhao, Xinhan
    ONCOLOGY LETTERS, 2017, 14 (06) : 7269 - 7275
  • [32] Antigenic differences between metastatic cells in bone marrow and primary tumours and the anti-MUC1 humoral immune response induced in breast cancer patients
    Croce, MV
    Isla-Larrain, M
    Tur, R
    Rabassa, ME
    Segal-Eiras, A
    CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (02) : 139 - 147
  • [33] Antigenic differences between metastatic cells in bone marrow and primary tumours and the anti-MUC1 humoral immune response induced in breast cancer patients
    M.V. Croce
    M. Isla-Larrain
    R. Tur
    M.E. Rabassa
    A. Segal-Eiras
    Clinical & Experimental Metastasis, 2004, 21 : 139 - 147
  • [34] Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour
    Lorgis, Veronique
    Algros, Marie Paule
    Villanueva, Cristian
    Chaigneau, Loic
    Thierry-vuillemin, Antoine
    Thierry Nguyen
    Demarchi, Martin
    Bazan, Fernando
    Sautiere, Jean Loup
    Maisonnette-Lescot, Yolande
    Ringenbach, Frederic
    Bontemps, Patrick
    Pivot, Xavier
    BREAST, 2011, 20 (03) : 284 - 287
  • [35] Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
    Tjensvoll, Kjersti
    Oltedal, Satu
    Heikkila, Reino
    Kvaloy, Jan Terje
    Gilje, Bjornar
    Reuben, James M.
    Smaaland, Rune
    Nordgard, Oddmund
    BMC CANCER, 2012, 12
  • [36] Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
    Kjersti Tjensvoll
    Satu Oltedal
    Reino Heikkilä
    Jan Terje Kvaløy
    Bjørnar Gilje
    James M Reuben
    Rune Smaaland
    Oddmund Nordgård
    BMC Cancer, 12
  • [37] Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer
    Ueno, Naoto T.
    Tahara, Rie K.
    Fujii, Takeo
    Reuben, James M.
    Gao, Hui
    Saigal, Babita
    Lucci, Anthony
    Iwase, Toshiaki
    Ibrahim, Nuhad K.
    Damodaran, Senthil
    Shen, Yu
    Liu, Diane D.
    Hortobagyi, Gabriel N.
    Tripathy, Debu
    Lim, Bora
    Chasen, Beth A.
    CANCER MEDICINE, 2020, 9 (03): : 1025 - 1032
  • [38] Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease
    Rossi, Sabrina
    Basso, Michele
    Strippoli, Antonia
    Dadduzio, Vincenzo
    Cerchiaro, Eleonora
    Le, Rosalba Bari
    D'Argento, Ettore
    Cassano, Alessandra
    Schinzari, Giovanni
    Barone, Carlo
    CLINICAL BREAST CANCER, 2015, 15 (05) : 307 - 312
  • [39] Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow
    C. Schindlbeck
    W. Janni
    N. Shabani
    B. Rack
    B. Gerber
    M. Schmitt
    N. Harbeck
    H. Sommer
    S. Braun
    K. Friese
    Breast Cancer Research and Treatment, 2004, 87 : 65 - 74
  • [40] Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow
    Schindlbeck, C
    Janni, W
    Shabani, N
    Rack, B
    Gerber, B
    Schmitt, M
    Harbeck, N
    Sommer, H
    Braun, S
    Friese, K
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (01) : 65 - 74
12345